Trends in CDMO of High Potency Drugs
Trends in CDMO of High Potency Drugs The major revenue-generating part of the pharmaceutical industry is the high potency drug market. The high potency drug market holds significant potential. There is great demand for oncology and other high potency drugs such as IV fluids and ADCs. With respect to demand, buyers are in need of high-capacity manufacturers who have lyophilization ability in injectable dosage forms, one who can reach their API OEL limits, and one who has experience in handling high potency drugs. But with regards to the side of supply, there aren’t sufficient CMOs who can meet the buyers’ needs as demanded. This article focuses on the regional distribution of suppliers and how the increasing demand for high potency active pharmaceutical ingredient drugs is affecting the CMO market regarding investing/upgrading in new capital, new facilities, capacity expansion, acquisitions, mergers, etc. Continue reading to learn more. Potential for Strong Growth Companies th...